Insider Purchase: Director at $VNRX Buys 20,000 Shares

Director Guy Archibald Innes purchased 20,000 shares of $VNRX on June 3, 2025, increasing his holdings by approximately 2.3%. Over the past six months, $VNRX insiders have made 9 open market purchases and no sales, with Innes, CEO Cameron John Reynolds, and CSO Jacob Vincent Micallef among the buyers. Recent hedge fund activity shows mixed sentiment, with LAGODA INVESTMENT MANAGEMENT, L.P. significantly increasing its position by 2,618,000 shares while ARMISTICE CAPITAL, LLC reduced its holdings by 275,465 shares in Q1 2025.

Analysis

Recent trading activity in VolitionRX Limited ($VNRX) reveals a strong bullish sentiment from company insiders, contrasted with a more mixed picture from institutional investors. A director, Guy Archibald Innes, recently acquired 20,000 shares for approximately $10,772 on June 3, 2025, increasing his holdings by 2.3% to 888,689 shares. This purchase is part of a significant pattern over the past six months, during which $VNRX insiders executed 9 purchases and zero sales. Notably, key executives including Innes (3 purchases, 376,582 shares, ~$210,771), President and CEO Cameron John Reynolds (3 purchases, 341,629 shares, ~$188,729), Timothy I Still (1 purchase, 87,382 shares, ~$49,999), and Chief Scientific Officer Jacob Vincent Micallef (2 purchases, 93,691 shares, ~$46,499) have all increased their stakes, signaling strong internal confidence. In terms of institutional activity reported for Q1 2025, LAGODA INVESTMENT MANAGEMENT, L.P. significantly increased its position by 2,618,000 shares (+34.6%), an estimated $1,492,521 investment, and VANGUARD GROUP INC added 69,393 shares (+10.9%). However, this was counterbalanced by ARMISTICE CAPITAL, LLC reducing its holdings by 275,465 shares (-3.2%), and complete divestitures by CITADEL ADVISORS LLC (68,192 shares) and MILLENNIUM MANAGEMENT LLC significantly cutting its stake by 49,820 shares (-82.2%), while GROUND SWELL CAPITAL, LLC also exited its position in Q4 2024. This indicates divergent views among larger market participants despite an overall strongly positive sentiment signal (0.6) and a specific VNRX sentiment of 0.7.

Key Decisions for Investors

• Investors should view the consistent and substantial open market purchases by multiple $VNRX insiders, including the CEO and CSO, as a strong indicator of management's positive outlook on the company's prospects.
• The divergent institutional activity, highlighted by LAGODA's significant position increase versus complete exits by firms like CITADEL ADVISORS and substantial reductions by MILLENNIUM MANAGEMENT, necessitates careful monitoring of future institutional holding disclosures to discern emerging consensus or continued dispersion.
• Given the strong insider buying and positive sentiment scores, investors might consider a bullish stance, but should also weigh the risk indicated by the notable institutional selling and the net decrease in the number of institutional investors holding positions.